Context Therapeutics Files 8-K
Ticker: CNTX · Form: 8-K · Filed: Dec 23, 2024 · CIK: 1842952
| Field | Detail |
|---|---|
| Company | Context Therapeutics Inc. (CNTX) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $15 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: CTX
TL;DR
CTX shares might move on this 8-K, but we need more info to know why.
AI Summary
Context Therapeutics Inc. filed an 8-K on December 23, 2024, to report other events. The filing does not contain specific details about the nature of these events, their financial impact, or any associated dates beyond the filing date itself.
Why It Matters
This 8-K filing indicates that Context Therapeutics Inc. has reported an event to the SEC, but the lack of specific details makes it difficult to assess the immediate impact on the company or its investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and lacks specific material information, thus posing a low immediate risk.
Key Players & Entities
- Context Therapeutics Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 2001 Market Street, Suite 3915, Unit #15 (address) — Principal executive offices
- Philadelphia, Pennsylvania (location) — City and State of principal executive offices
- 19103 (zip_code) — Zip code of principal executive offices
- (267) 225-7416 (phone_number) — Registrant's telephone number
FAQ
What specific event is Context Therapeutics Inc. reporting in this 8-K filing?
The filing is categorized under 'Other Events' and does not specify the nature of the event.
When was this 8-K report filed?
The report was filed on December 23, 2024.
What is the principal executive office address for Context Therapeutics Inc.?
The principal executive offices are located at 2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103.
What is the company's telephone number?
The company's telephone number is (267) 225-7416.
What state is Context Therapeutics Inc. incorporated in?
Context Therapeutics Inc. is incorporated in Delaware.
Filing Stats: 406 words · 2 min read · ~1 pages · Grade level 10.2 · Accepted 2024-12-23 09:26:07
Key Financial Figures
- $0.001 — mon Stock CNTX The Nasdaq Stock Market $0.001 par value per share Indicate by check
- $15 million — gregate gross proceeds of approximately $15 million. The shares were sold pursuant to a sal
Filing Documents
- cntx-20241223.htm (8-K) — 21KB
- 0001842952-24-000087.txt ( ) — 152KB
- cntx-20241223.xsd (EX-101.SCH) — 2KB
- cntx-20241223_lab.xml (EX-101.LAB) — 24KB
- cntx-20241223_pre.xml (EX-101.PRE) — 14KB
- cntx-20241223_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On December 23, 2024, Context Therapeutics Inc. (the "Company") sold 14,705,882 shares of its common stock, for aggregate gross proceeds of approximately $15 million. The shares were sold pursuant to a sales agreement with Leerink Partners LLC (the "Agent") dated December 2, 2024. The Agent has informed the Company that the shares were purchased by MPM BioImpact LLC.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 23, 2024 Context Therapeutics Inc. By: /s/ Martin A. Lehr Name: Martin A. Lehr Title: Chief Executive Officer